Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis

被引：0
|
作者：
J. Hillengass
A. D. Ho
H. Goldschmidt
R. Waldherr
T. M. Moehler
机构：
[1] University Hospital of Heidelberg,Department of Hematology, Oncology and Rheumatology
[2] Gemeinschaftspraxis Pathologie,undefined
来源：
International Journal of Hematology | 2008年 / 88卷
关键词：
Cryoglobulinemia; Multiple myeloma; Stem cell transplantation; Immune reset;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We present a case report of a patient with cryoglobulin-vasculitis caused by multiple myeloma in Durie/Salmon stage I refractory to conventional therapy modalities treated with high-dose chemotherapy followed by autologous blood stem cell transplantation. While clinical symptoms of vasculitis disappeared, elevated cryoglobulin levels persisted. Therefore we conclude that the relief of symptoms was caused by an immunomodulation induced by the autologous stem cell transplantation.
引用
收藏
页码：454 / 456
页数：2
相关论文
共 50 条
  • [31] High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma
    Benson, Don M., Jr.
    Elder, Patrick J.
    Lin, Thomas S.
    Blum, William
    Penza, Sam
    Avalos, Belinda
    Copelan, Edward
    Farag, Sherif S.
    LEUKEMIA RESEARCH, 2007, 31 (08) : 1069 - 1075
  • [32] Transient complete remission of metastasized Merkel cell carcinoma by high-dose polychemotherapy and autologous peripheral blood stem cell transplantation
    Waldmann, V
    Goldschmidt, H
    Jäckel, A
    Deichmann, M
    Hegenbart, U
    Hartschuh, W
    Ho, A
    Näher, H
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (04) : 837 - 839
  • [33] High-dose melphalan with G-CSF-stimulated whole blood rescue followed by stem cell harvesting and busulphan/cyclophosphamide with autologous stem cell transplantation in multiple myeloma
    PC Huijgens
    HM Dekker-van Roessel
    AR Jonkhoff
    GC Admiraal
    S Zweegman
    GJ Schuurhuis
    GJ Ossenkoppele
    Bone Marrow Transplantation, 2001, 27 : 925 - 931
  • [34] Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma
    Shah, N.
    Thall, P. F.
    Fox, P. S.
    Bashir, Q.
    Shah, J. J.
    Parmar, S.
    Lin, P.
    Kebriaei, P.
    Nieto, Y.
    Popat, U. R.
    Hosing, C. M.
    Cornelison, A.
    Shpall, E. J.
    Orlowski, R. Z.
    Champlin, R. E.
    Qazilbash, M. H.
    LEUKEMIA, 2015, 29 (09) : 1945 - 1948
  • [35] High-dose melphalan with G-CSF-stimulated whole blood rescue followed by stem cell harvesting and busulphan/cyclophosphamide with autologous stem cell transplantation in multiple myeloma
    Huijgens, PC
    Dekker-van Roessel, HM
    Jonkhoff, AR
    Admiraal, GC
    Zweegman, S
    Schuurhuis, GJ
    Ossenkoppele, GJ
    BONE MARROW TRANSPLANTATION, 2001, 27 (09) : 925 - 931
  • [36] Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy
    Bo-Hee Lee
    Seung Hwan Shin
    Chang-Ki Min
    Ho-Young Yhim
    Jae-Yong Kwak
    Jeong-A Kim
    International Journal of Hematology, 2013, 97 : 634 - 639
  • [37] High-dose idarubicin, busulphan and melphalan for autologous stem cell transplantation in multiple myeloma responsive to DAV chemotherapy: Comparison with a historical control
    Capria, S
    Petrucci, MT
    Pulsoni, A
    Ribersani, M
    Baldacci, E
    de Propris, MS
    Meloni, G
    ACTA HAEMATOLOGICA, 2006, 115 (1-2) : 9 - 14
  • [38] High-dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma
    Aydin, Mesire
    Tang, Man Wai
    Wondergem, Marielle J.
    de Leeuw, David C.
    Wegman, Jurgen J.
    Biemond, Bart J.
    van de Donk, Niels W. C. J.
    Zweegman, Sonja
    Meijer, Ellen
    Nur, Erfan
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (06) : E67 - E70
  • [39] Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy
    Lee, Bo-Hee
    Shin, Seung Hwan
    Min, Chang-Ki
    Yhim, Ho-Young
    Kwak, Jae-Yong
    Kim, Jeong-A
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (05) : 634 - 639
  • [40] Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma
    S M A Kazmi
    R M Saliba
    M Donato
    M Wang
    C Hosing
    S Qureshi
    P Anderlini
    U Popat
    R E Champlin
    S A Giralt
    M H Qazilbash
    Bone Marrow Transplantation, 2011, 46 : 510 - 515
12345